SuperworthSyndax Pharmaceuticals market cap SNDX
Share price times shares outstanding: what the whole company sells for, since 2016.
- Today, Oct 23, 2026
- $1.2B
- Highest close in our data
- $2.2B
- Apr 2026
Syndax Pharmaceuticals is worth $1.2B at the close on Oct 23, 2026, at $13.40 a share.
That is up 3% over the last year and up 27% over five years.
Its highest close in our data was $2.2B in Apr 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $1.2B | $1.2B | $2.2B | −35% |
| 2025 | $1.9B | $774.4M | $1.9B | +70% |
| 2024 | $1.1B | $1.1B | $2.1B | −28% |
| 2023 | $1.5B | $799.8M | $1.7B | −2% |
| 2022 | $1.5B | $739.9M | $1.5B | +42% |
| 2021 | $1.1B | $688M | $1.2B | +19% |
| 2020 | $908.9M | $191.1M | $1B | +275% |
| 2019 | $242.6M | $117.3M | $277.6M | +142% |
| 2018 | $100.3M | $90.2M | $351.5M | −53% |
| 2017 | $213.7M | $121.5M | $280.2M | +64% |
| 2016 | $130.4M | $130.4M | $270.3M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Syndax Pharmaceuticals' size, closest first, today.
| Company | Market cap |
|---|---|
| SNDXSyndax Pharmaceuticals | $1.2B |
| OMEROmeros | $1.2B |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| PCRXPacira BioSciences | $1.5B |
| ANABAnaptysbio | $1.5B |
| PAHCPhibro Animal Health | $1.6B |
| ANIPANI Pharmaceuticals | $1.7B |
| ABUSArbutus Biopharma | $831M |
| COLLCollegium Pharmaceutical | $747.5M |
| HRMYHarmony Biosciences | $2.1B |
| PBHPrestige Consumer Healthcare | $2.3B |
| Peer median | $1.5B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Syndax Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.